Table of Contents

company-logo

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1; AUTO6NG, a programmed T cell investigational therapy, which is in preclinical trail targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate that is in a Phase I clinical trial for multiple myeloma. It also focuses on developing AUTO5, a hematological product candidate, which is in preclinical development. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.

Autolus Therapeutics Dividend Announcement

• Autolus Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Autolus Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Autolus Therapeutics Dividend History

Autolus Therapeutics Dividend Yield

Autolus Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Autolus Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Autolus Therapeutics Financial Ratios

P/E ratio-2.93
PEG ratio-0.94
P/B ratio1.66
ROE-63.65%
Payout ratio0.00%
Current ratio13.69
Quick ratio13.69
Cash Ratio12.52

Autolus Therapeutics Dividend FAQ

Does Autolus Therapeutics stock pay dividends?
Autolus Therapeutics does not currently pay dividends to its shareholders.
Has Autolus Therapeutics ever paid a dividend?
No, Autolus Therapeutics has no a history of paying dividends to its shareholders. Autolus Therapeutics is not known for its dividend payments.
Why doesn't Autolus Therapeutics pay dividends?
There are several potential reasons why Autolus Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Autolus Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Autolus Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Autolus Therapeutics a dividend aristocrat?
Autolus Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Autolus Therapeutics a dividend king?
Autolus Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Autolus Therapeutics a dividend stock?
No, Autolus Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Autolus Therapeutics stocks?
To buy Autolus Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Autolus Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.